Agilent Technologies Inc 1A
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- €150.10
- Day Range
- €149.70–151.95
- 52-Week Range
- €93.92–155.35
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 281.93M
- Market Cap
- $43.14B
- Volume/Avg
- 207 / 37
Key Statistics
- Price/Earnings (Normalized)
- 29.36
- Price/Sales
- 6.84
- Dividend Yield (Trailing)
- 0.58%
- Dividend Yield (Forward)
- 0.60%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 1.34%
Company Profile
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 18,200
- Website
- https://www.agilent.com
Competitors
Valuation
|
Metric
|
1A
|
WAT
|
DHR
|
|---|---|---|---|
Price/Earnings (Normalized) | 29.36 | 31.71 | 27.07 |
Price/Book Value | 6.74 | 2.80 | 2.94 |
Price/Sales | 6.84 | 6.99 | 6.22 |
Price/Cash Flow | 26.59 | 27.06 | 21.80 |
Price/Earnings
1A
WAT
DHR
Financial Strength
|
Metric
|
1A
|
WAT
|
DHR
|
|---|---|---|---|
Quick Ratio | 1.41 | 1.05 | 1.03 |
Current Ratio | 2.05 | 1.86 | 1.65 |
Interest Coverage | 16.08 | 2.23 | 16.95 |
Quick Ratio
1A
WAT
DHR
Profitability
|
Metric
|
1A
|
WAT
|
DHR
|
|---|---|---|---|
Return on Assets (Normalized) | 13.27% | 7.79% | 5.34% |
Return on Equity (Normalized) | 24.92% | 13.28% | 8.59% |
Return on Invested Capital (Normalized) | 16.95% | 10.35% | 6.45% |
Return on Assets
1A
WAT
DHR
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|ltwlTL^ | LOCK|vdn | $243B | |||
| Danaher Corp
DHR
| LOCK|kjR?&&Qm | LOCK|>#% | $155B | |||
| Agilent Technologies Inc
A
| LOCK|^LX@!G> | LOCK|MW! | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|@%%>&@ | LOCK|h<&#V | $43B | |||
| Waters Corp
WAT
| LOCK|$!Zz>? | LOCK|s& | $43B | |||
| Illumina Inc
ILMN
| LOCK|Z!R!&q | LOCK|<t%f | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|^qlt>tv | LOCK|$w | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|#sz^HY!& | LOCK|h&&r | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|<fSqnTL | LOCK|QPbD | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|#<LcM?q | LOCK|NY>m | $25B |
United States